Brief: Jazz Pharmaceuticals Enters Amendment No. 4 To Credit Agreement On Sept 23, 2026
23/09/2026 22:23
BRIEF-Jazz Pharmaceuticals Enters Amendment No. 4 To Credit Agreement On Sept 23, 2026 Sept 24 (Reuters) - Jazz Pharmaceuticals PLC JAZZ.O:
JAZZ PHARMACEUTICALS - UNIT ENTERS AMENDMENT NO. 4 TO CREDIT AGREEMENT ON SEPT 23, 2026 - SEC FILING
JAZZ PHARMACEUTICALS - UNIT BORROWS $273.31 MILLION IN ADDITIONAL TRANCHE B-3 DOLLAR TERM LOANS - SEC FILING
JAZZ PHARMACEUTICALS - TRANCHE B-3 DOLLAR TERM LOANS MATURE ON MAY 5, 2033 - SEC FILING
Further company coverage: JAZZ.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jazz Pharmaceuticals
See all newsBrief: Jazz Pharmaceuticals Enters Amendment No. 4 To Credit Agreement On Sept 23, 2026
U.S. STOCKS ON THE MOVE-BWX Technologies, Synopsys,Burlington Stores
U.S. STOCKS ON THE MOVE-Jazz Pharmaceuticals, Celularity, Infleqtion
Jazz Pharma dips after upsized $1.1 bln convertible offering
Brief: Jazz Pharmaceuticals Announces Private Offering Of $1.0 Billion Of Exchangeable Senior Notes Due 2032